EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 2, 2009, Pages 313-318

  Sasaki, Hidefumi ^a   Okuda, Katsuhiro ^a   Shimizu, Shigeki ^a   Takada, Minoru ^b   Kawahara, Masaaki ^b   Kitahara, Naoto ^b   Okumura, Meinoshin ^b   Matsumura, Akihide ^b   Iuchi, Keiji ^b   Kawaguchi, Tomoya ^b   Kubo, Akihito ^b   Kawano, Osamu ^a   Yukiue, Haruhiro ^a   Yano, Motoki ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

Author keywords

EGFR; Lung cancer; Polymorphism; R497K

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; EXON; GENETIC POLYMORPHISM; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS;

AMINO ACID SUBSTITUTION; CARCINOMA, NON-SMALL-CELL LUNG; DNA, NEOPLASM; EXONS; HUMANS; LUNG NEOPLASMS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 64849106917     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-008-0464-5     Document Type: Article

References (23)

1. Bandres E, Brarricarte R, Cantero C, Honorato B, Malumbres R, Zarate R, Alcalde J, Garcia-Foncillas J (2007) Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients. Oral Oncol 43:713-719
2. Brandt B, Meyer-Staeckling S, Schmidt H, Agelopoulos K, Buerger H (2006) Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response. Clin Cancer Res 12:7252-7260
3. Dubey S, Stephenson P, Levy DE, Miller JA, Keller SM, Schiller JH, Johnson DH, Kolesar JM (2006) EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer. J Thorac Oncol 1:406-412
4. Dumontet C, Isaac S, Souquet PJ, Bejui-Thivolet F, Pacheco Y, Peloux N, Frankfurter A, Luduena R, Perol M (2005) Expression of class III beta tubulin in non-small cell lung cancer is correlated with resistance to taxane chemotherapy. Bull Cancer 92:E25-E30
5. Endo K, Konishi A, Sasaki H, Takada M, Tanaka H, Okumura M, Kawahara M, Sugiura H, Kuwabara Y, Fukai I, Matsumura A, Yano M, Kobayashi Y, Mizuno K, Haneda H, Suzuki E, Iuchi K, Fujii Y (2005) Epidermal growth factor receptor gene mutation in nonsmall cell lung cancer using highly sensitive and fast TaqMan PCR assay. Lung Cancer 50:375-384
6. Fukushima T, Favereaux F, Huang H, Shimizu T, Yonezawa Y, Nakazato Y, Ohagki H (2006) Genetic alterations in primary glioblastomas in Japan. J Neuropathol Exp Neurol 65:12-18
7. Ginsberg RJ, Kris K, Armstrong G (1993) Cancer of the lung. In: Principles and practice of oncology. Lippincott 1993; Fourth Edition, Philadelphia 673-682
8. Kang D, Gridley G, Huang WY, Engel LS, Winn DM, Brown LM, Bravo-Otero E, Wu T, Diehl SR, Hayes RB (2005) Microsatellite polymorphisms in the epidermal growth factor receptor (EGFR) gene and the transforming growth factor-alpha (TGFA) gene and risk of oral cancer in Puerto Rico. Pharmacogenet Genomics 15:343-347
9. Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, Perry MC, Livingston RB, Johnson DH (2000) A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small cell lung cancer. N Engl J Med 343:1217-1222
10. Liu G, Gurubhagavatula S, Zhou W, Wang Z, Yeap BY, Asomaning K, Su L, Heist R, Lynch TJ, Christiani DC (2008) Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with geWtinib. Pharmacogenomics J 8:129-138
11. Liu W, Wu X, Zhang W, Montenegro RC, Fackenthal DL, Spitz JA, Huff LM, Innocenti F, Das S, Cook EH Jr, Cox NJ, Bates SE, Ratain MJ (2007) Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines. Clin Cancer Res 13:6788-6795
12. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to geWtinib. New Eng J Med 350:2129-2139
13. Moriai T, Kobrin MS, Hope C, Speck L, Korc M (1994) A variant epidermal growth factor receptor exhibits altered type a transforming growth factor binding and transmembrane signaling. Proc Natl Acad Sci USA 91:10217-10221
14. Nicolson RI, Gee JM, Harper ME (2001) EGFR and cancer prognosis. Eur J Cancer 37:S9-S15
15. Olaussen KA, Dunant A, Fouret P, Brambilla E, Andre F, Haddad Y, Taranchon E, Filipits M, Pirker R, Popper JH, Stahel R, Sabatier L, Pignon JP, Tursz T, Le Chevalier T, Soria JC (2006) DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 355:983-991
16. Onn A, Correa AM, Gilcrease M, Isobe T, Massarelli E, Bucane CD, O'Reilly MS, Hong WK, Fidler IJ, Putnum JB, Herbst RS (2004) Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res 10:136-143
17. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Seller WR, Johnson BE, Meyerson M (2004) EGFR mutations in lung cancer: correlation with clinical response to geWtinib therapy. Science 304:1497-1500
18. Pao W, Miller V, Zakowski M, Diherty J, Politi K, Sarkaria I, Singth B, Heelman R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kri M, Varmus H (2004) EGF receptor gene mutations are common in lung cancers from 'never smokers" and are associated with sensitivity of tumors to geWtinib and elrotinib. Proc Natl Acad Sci USA 101:13306-13311
19. Sasaki H, Endo K, Takada M, Kawahara M, Kitahara H, Tanaka H, Okumura M, Matsumura A, Iuchi K, Kawaguchi T, Kawano O, Yukiue H, Yokoyama T, Yano M, Fujii Y (2007) EGFR exon 20 insertion mutation in Japanese lung cancer. Lung Cancer 58:324-328
20. Shintani S, Matsuo K, Crohin CC, McBride J, Tsuji T, DonoV RB, Posner M, Todd R, Wong DT (1999) Intragenic mutation analysis of the human epidermal growth factor receptor (EGFR) gene in malignant human oral keratinocytes. Cancer Res 59:4142-4147
21. Wang WS, Chen PM, Chiou TJ, Liu JH, Lin JK, Lin TC et al (2007) Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma. Clin Cancer Res 12:3597-3603
22. Zhang W, Park DJ, Lu B, Yang DY, Gordon M, Groshen S, Yun J, Press OA, Vallbohmer D, Rhodes K, Lenz HJ (2005) Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation. Clin Cancer Res 11:600-605
23. Zhang W, Stabile LP, Keohavong P, Romkes M, Grandis JR, Traynor AM, Siegfried JM (2006) Mutation and polymorphism in the EGFR-TK domain associated with lung cancer. J Thorac Oncol 1:635-647